Cargando…

Emerging Therapies for Acute Coronary Syndromes

In the majority of cases acute coronary syndromes (ACS) are caused by activation and aggregation of platelets and subsequent thrombus formation leading to a decrease in coronary artery blood flow. Recent focus on the treatment of ACS has centered on reducing the response of platelets to vascular inj...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lilly, Scott M., Wilensky, Robert L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2011
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199568/ https://www.ncbi.nlm.nih.gov/pubmed/22028691 http://dx.doi.org/10.3389/fphar.2011.00061

Ejemplares similares

The Use of Beta Blockers in Takotsubo Syndrome as Compared to Acute Coronary Syndrome
por: Kummer, Marvin, et al.
Publicado: (2020)

Iron metabolism-related genes reveal predictive value of acute coronary syndrome
por: Xu, Cong, et al.
Publicado: (2022)

The Therapeutic Efficacy of Danhong Injection Combined With Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
por: Zou, Jun-Bo, et al.
Publicado: (2018)

Platelet Function and Risk of Bleeding in Patients With Acute Coronary Syndrome Following Tirofiban Infusion
por: Li, Xiaoye, et al.
Publicado: (2019)

Application of MAT Methodology in the Evaluation of Prescribing Adherence to Clinical Practice Guidelines for Secondary Prevention of Coronary Heart Disease in Post-Acute Coronary Syndrome Patients in Kuwait
por: Al-Taweel, Dalal, et al.
Publicado: (2021)

Comparative efficacy and safety of antiplatelet or anticoagulant therapy in patients with chronic coronary syndromes after percutaneous coronary intervention: A network meta-analysis of randomized controlled trials
por: Lin, Yaowang, et al.
Publicado: (2022)

Impact of Implementing CYP2C19 Genotype-Guided Antiplatelet Therapy on P2Y(12) Inhibitor Selection and Clinical Outcomes in Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention: A Real-World Study in China
por: Zhang, Yi, et al.
Publicado: (2021)

Pharmacist-Led Intervention to Enhance Medication Adherence in Patients With Acute Coronary Syndrome in Vietnam: A Randomized Controlled Trial
por: Nguyen, Thang, et al.
Publicado: (2018)

Comparison of Safety and Efficacy Between Clopidogrel and Ticagrelor in Elderly Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
por: Zhao, Xiangkai, et al.
Publicado: (2021)

Development and Validation of a Novel Tool for the Prediction of Clopidogrel Response in Chinese Acute Coronary Syndrome Patients: The GeneFA Score
por: Wu, Hongyi, et al.
Publicado: (2022)

Prognostic Impacts of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome Patients Without Heart Failure
por: Chen, Runzhen, et al.
Publicado: (2022)

Porcine Models of Accelerated Coronary Atherosclerosis: Role of Diabetes Mellitus and Hypercholesterolemia
por: Hamamdzic, Damir, et al.
Publicado: (2013)

Potential drug-drug interactions in drug therapy for older adults with chronic coronary syndrome at hospital discharge: A real-world study
por: Zhao, Mei, et al.
Publicado: (2022)

Comparative Efficacy of Danshen Class Injections for Treating Acute Coronary Syndrome: A Multidimensional Bayesian Network Meta-Analysis of Randomized Controlled Trials
por: Guo, Siyu, et al.
Publicado: (2020)

Effects of sodium tanshinone IIA sulfonate injection on inflammatory factors and vascular endothelial function in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomized clinical trials
por: Kan, Zunqi, et al.
Publicado: (2023)

Novel and Emerging Therapies for Inflammatory Bowel Disease
por: Al-Bawardy, Badr, et al.
Publicado: (2021)

Acute Radiation Syndrome and the Microbiome: Impact and Review
por: Hollingsworth, Brynn A., et al.
Publicado: (2021)

Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes
por: Gasperetti, Tracy, et al.
Publicado: (2021)

Emerging Therapies in the Management of Advanced-Stage Gastric Cancer
por: Kumar, Vivek, et al.
Publicado: (2018)

Emerging pharmaceutical therapeutics and delivery technologies for osteoarthritis therapy
por: Shentu, Cheng-Yu, et al.
Publicado: (2022)

Current, emerging, and potential therapies for non-alcoholic steatohepatitis
por: Yang, Zhen, et al.
Publicado: (2023)

Corrigendum: Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes
por: Gasperetti, Tracy, et al.
Publicado: (2021)

The Successful Rapid Adjustment of Blood Glucose in a Patient With Acute Coronary Syndrome, Renal Insufficiency, and Diabetes: A Case Report of Management Coordinated by Clinical Pharmacists and Clinicians
por: Shi, Fang-Hong, et al.
Publicado: (2020)

Suxiao Jiuxin Pill attenuates acute myocardial ischemia via regulation of coronary artery tone
por: Li, Sa, et al.
Publicado: (2023)

Rituximab Therapy for Primary Sjögren’s Syndrome
por: Chen, Yi Han, et al.
Publicado: (2021)

Emerging Significance of Ginsenosides as Potentially Reversal Agents of Chemoresistance in Cancer Therapy
por: Xu, Jin-Feng, et al.
Publicado: (2021)

Gene Mutations as Emerging Biomarkers and Therapeutic Targets for Relapsed Acute Myeloid Leukemia
por: Aziz, Habsah, et al.
Publicado: (2017)

Emerging Cell-Based Therapies in Chronic Lung Diseases: What About Asthma?
por: Cereta, Andressa Daronco, et al.
Publicado: (2021)

Progress in understanding and treating idiopathic pulmonary fibrosis: recent insights and emerging therapies
por: Guo, Hehua, et al.
Publicado: (2023)

Secondary Prevention Medical Therapy and Outcomes in Patients With Myocardial Infarction With Non-Obstructive Coronary Artery Disease
por: Paolisso, Pasquale, et al.
Publicado: (2020)

Incidence and impact of antiplatelet therapy cessation among very older patients with stable coronary artery disease
por: Zou, Xiao, et al.
Publicado: (2023)

Impact of COVID on Emergency Presentations With Acute Coronary Syndrome
por: Bray, J., et al.
Publicado: (2022)

Cytokine Release Syndrome Is an Independent Risk Factor Associated With Platelet Transfusion Refractoriness After CAR-T Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia
por: Liu, Yadan, et al.
Publicado: (2021)

Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option
por: Kraft, Manuel, et al.
Publicado: (2021)

The Molecular Links of Re-Emerging Therapy: A Review of Evidence of Brahmi (Bacopa monniera)
por: Mathur, Deepali, et al.
Publicado: (2016)

Combination of an Autophagy Inducer and an Autophagy Inhibitor: A Smarter Strategy Emerging in Cancer Therapy
por: Liu, Ting, et al.
Publicado: (2020)

Mapping knowledge landscapes and emerging trends of sonodynamic therapy: A bibliometric and visualized study
por: Wu, Zhenjiang, et al.
Publicado: (2023)

Ramipril Alleviates Oxaliplatin-Induced Acute Pain Syndrome in Mice
por: Bouchenaki, Hichem, et al.
Publicado: (2021)

Association between in-hospital guideline adherence and postdischarge major adverse outcomes of patients with acute coronary syndrome in Vietnam: a prospective cohort study
por: Nguyen, Thang, et al.
Publicado: (2017)

Exploring the “gene–protein–metabolite” network of coronary heart disease with phlegm and blood stasis syndrome by integrated multi-omics strategy
por: Yang, Guang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_23mc7p1u8f608kpdjdgghiqrvj